No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Medicus Pharma Ltd. Announces Change of Auditor
Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success With Favorable Buy Rating
Brookline Capital Initiates Medicus Pharma(MDCX.US) With Buy Rating, Announces Target Price $12
Medicus Pharma Analyst Ratings
Maxim Group Initiates Medicus Pharma(MDCX.US) With Buy Rating, Announces Target Price $10
Medicus Pharma Shares Are Trading Higher After the Company Its INAD File No.013880 Was Used as Part of a Major Species Designation From the FDA.